BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd and specializes in investments in the healthcare and biotechnology sector in Australia. The fund focuses on various sectors including post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Investments in post-genomics include functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. The focus within stem cell biology is on stem cell therapies, while in convergent technologies, investments include biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. Within the silicon biology sector, the fund invests in structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. The fund invests in both listed and unlisted companies.